Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | SYK | P43405 | 1/20 | 0.42 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 3/20 | 0.41 |
| ▸ | CTSK | P43235 | 3/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16379307 | 0.94 | MEN1 (0.46) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL13960156 | 0.94 | MEN1 (0.46) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL12475162 | 0.92 | MEN1 (0.49) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL2284087 | 0.92 | MEN1 (0.45) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL15571118 | 0.91 | MEN1 (0.44) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL15571119 | 0.91 | MEN1 (0.44) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL1222350 | 0.90 | TDP1 (0.49) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL1222348 | 0.90 | TDP1 (0.49) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL5352030 | 0.90 | MEN1 (0.46) | MEN1GAAKMT2ATDP1CA1 | |
| SCHEMBL3166361 | 0.90 | TDP1 (0.49) | MEN1GAAKMT2ATDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529639-A | Anticorrosive phenolic epoxy resin coating for oil pipe and preparation method thereof | 上海泰梧科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-117209887-B | High-toughness durable polypropylene material and preparation process thereof | 珠海市金塑塑料有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117209887-A | High-toughness durable polypropylene material and preparation process thereof | 广东科净塑料制品有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-20260008777-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-01-08 | — | — | US | disclosed |
| US-12358951-B2 | Cyclic peptide antibiotics | GENENTECH, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| EP-3592761-B1 | NEW ANTIBACTERIAL PRODUCTS | UNIV LIVERPOOL (GB) | 2025-05-14 | — | — | EP | disclosed |
| CN-119529639-A | Anticorrosive phenolic epoxy resin coating for oil pipe and preparation method thereof | 上海泰梧科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20240374595-A1 | SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME | ARBUTUS BIOPHARMA CORPORATION (CA) | 2024-11-14 | — | — | US | disclosed |
| US-20240327463-A1 | ANTIBACTERIAL PRODUCTS | THE UNIVERSITY OF LIVERPOOL (GB) | 2024-10-03 | — | — | US | disclosed |
| US-12083118-B2 | Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same | ARBUTUS BIOPHARMA CORPORATION (CA) | 2024-09-10 | — | — | US | disclosed |
| EP-3868409-B1 | THIOPHENOL-MALEIMIDE AND BROM-MALEIMIDE DERIVATIVES AS LINKER FOR ANTIBODY-DRUG CONJUGATES (ADC) FOR TREATING TUMORS | REMEGEN CO LTD (CN) | 2024-07-17 | — | — | EP | disclosed |
| US-5808091-A | DIAGNOSTIC IMAGING AGENT | BRACCO INTERNATIONAL B.V. | 1998-09-15 | — | — | US | disclosed |
| US-5712417-A | Inhibitors of retroviral proteases | ABBOTT LABORATORIES (US) | 1998-01-27 | — | — | US | disclosed |
| US-5688487-A | Diagnostic imaging methods using rhenium and technetium complexes containing a hypoxia-localizing moiety | BRACCO INTERNATIONAL B.V. (NL) | 1997-11-18 | — | — | US | disclosed |
| EP-0544412-B1 | Rhenium and technetium complexes containing a hypoxia-localizing moiety | BRACCO INT BV (NL) | 1997-07-23 | — | — | EP | disclosed |
| EP-0544412-A2 | Rhenium and technetium complexes containing a hypoxia-localizing moiety | BRACCO INTERNATIONAL B.V. (NL) | 1993-06-02 | — | — | EP | disclosed |
| EP-0428849-A2 | Retroviral protease inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-05-29 | — | — | EP | disclosed |
| US-4933470-A | Method of synthesis of vicinal diamines | NEORX CORPORATION (US) | 1990-06-12 | — | — | US | disclosed |
| EP-0144825-B1 | CYCLIC GUANIDINYL THIO CARBAPENEMS | MERCK & CO. INC. (US) | 1989-07-05 | — | — | EP | disclosed |
| US-4717728-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1988-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12083118-B2 | Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same | HAVCR2, HMBS, BCL3 | MEN1 1368/4885GAA 2530/4885KMT2A 383/4885 |
| US-12358951-B2 | Cyclic peptide antibiotics | NPPA, LNPEP, CLPP | MEN1 4359/4885GAA 844/4885KMT2A 1737/4885 |
| US-20260008777-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | PTPRO, PTPRC, PTPRR | MEN1 4235/4885GAA 3227/4885KMT2A 1717/4885 |
| US-20240374595-A1 | SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME | HAVCR2, HMBS, CDV3 | MEN1 1507/4885GAA 2288/4885KMT2A 400/4885 |
| US-20240327463-A1 | ANTIBACTERIAL PRODUCTS | DBI, PDIA5, ABCB11 | MEN1 2942/4885GAA 504/4885KMT2A 4485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.